Kristina Aleksandrova Todorova, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Aging | 1 | 2020 | 141 | 0.620 |
Why?
|
Dermatologic Agents | 1 | 2020 | 306 | 0.520 |
Why?
|
Y-Box-Binding Protein 1 | 2 | 2021 | 41 | 0.350 |
Why?
|
Skin Neoplasms | 5 | 2024 | 5801 | 0.300 |
Why?
|
Ultraviolet Rays | 3 | 2020 | 1078 | 0.230 |
Why?
|
Skin | 2 | 2024 | 4466 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 541 | 0.150 |
Why?
|
Cosmetic Techniques | 1 | 2020 | 145 | 0.150 |
Why?
|
Administration, Cutaneous | 1 | 2020 | 711 | 0.150 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13625 | 0.140 |
Why?
|
Keratinocytes | 2 | 2018 | 792 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 996 | 0.130 |
Why?
|
Keratosis, Seborrheic | 1 | 2015 | 27 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 104 | 0.130 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2018 | 417 | 0.120 |
Why?
|
Interferons | 2 | 2008 | 705 | 0.120 |
Why?
|
Skin Diseases | 2 | 2021 | 1090 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2347 | 0.110 |
Why?
|
rho GTP-Binding Proteins | 1 | 2014 | 277 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2024 | 4030 | 0.100 |
Why?
|
Receptor, Notch1 | 1 | 2014 | 497 | 0.090 |
Why?
|
DNA Repair | 2 | 2008 | 2039 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2218 | 0.080 |
Why?
|
Cell Survival | 2 | 2015 | 5793 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2448 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3754 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2824 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3606 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 689 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3523 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2003 | 3123 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 1483 | 0.050 |
Why?
|
Transfection | 2 | 2008 | 5781 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8633 | 0.050 |
Why?
|
Proteome | 1 | 2010 | 1847 | 0.040 |
Why?
|
Standard of Care | 1 | 2024 | 551 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2010 | 1655 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2005 | 1744 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2008 | 1882 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 696 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2024 | 559 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12106 | 0.040 |
Why?
|
Chemokine CXCL1 | 1 | 2018 | 107 | 0.040 |
Why?
|
DNA Damage | 1 | 2008 | 2442 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2021 | 480 | 0.040 |
Why?
|
Camptothecin | 1 | 2021 | 589 | 0.040 |
Why?
|
Proteomics | 1 | 2010 | 3803 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29878 | 0.030 |
Why?
|
HeLa Cells | 3 | 2008 | 3107 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 1994 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2018 | 522 | 0.030 |
Why?
|
Epidermis | 1 | 2018 | 529 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2018 | 698 | 0.030 |
Why?
|
Doxorubicin | 1 | 2021 | 2202 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10427 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6132 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 18937 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
Wound Healing | 1 | 2024 | 2781 | 0.030 |
Why?
|
Humans | 14 | 2024 | 759098 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9470 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1665 | 0.030 |
Why?
|
Plasmids | 2 | 2008 | 2277 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3812 | 0.020 |
Why?
|
Nitrogen Isotopes | 1 | 2010 | 85 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23328 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2010 | 461 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2936 | 0.020 |
Why?
|
Animals | 5 | 2024 | 167531 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2010 | 388 | 0.020 |
Why?
|
Mice | 4 | 2021 | 80993 | 0.020 |
Why?
|
Nitric Oxide | 2 | 2008 | 2141 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3443 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2018 | 11461 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10746 | 0.020 |
Why?
|
Comet Assay | 1 | 2008 | 74 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1746 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4111 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2010 | 983 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9334 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1180 | 0.020 |
Why?
|
Amino Acids | 1 | 2010 | 1715 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2008 | 818 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2190 | 0.010 |
Why?
|
Buffers | 1 | 2003 | 144 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2003 | 6538 | 0.010 |
Why?
|
Protein Denaturation | 1 | 2003 | 242 | 0.010 |
Why?
|
Drug Stability | 1 | 2003 | 290 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11046 | 0.010 |
Why?
|
Solubility | 1 | 2003 | 1087 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 687 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29559 | 0.010 |
Why?
|
Escherichia coli | 2 | 2003 | 4222 | 0.010 |
Why?
|
Mutagenesis | 1 | 2003 | 1233 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2003 | 1494 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2814 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3087 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4170 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2008 | 3664 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 3800 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 2016 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7583 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4445 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14648 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15638 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20027 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2008 | 5637 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12442 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13439 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2003 | 3062 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17611 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18094 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16878 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12765 | 0.000 |
Why?
|
Female | 2 | 2014 | 390174 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2008 | 21019 | 0.000 |
Why?
|